1,977
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype

, , , , , , , , , , , , & ORCID Icon show all
Article: 1940674 | Received 25 Jan 2021, Accepted 03 Jun 2021, Published online: 28 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Quanjun Yang, Juan Hao, Mengyi Chi, Yaxian Wang, Bo Xin, Jinglu Huang, Jin Lu, Jie Li, Xipeng Sun, Chunyan Li, Yan Huo, Jianping Zhang, Yonglong Han & Cheng Guo. (2022) Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism. OncoImmunology 11:1.
Read now

Articles from other publishers (11)

Sophie Mouillet-Richard, Angélique Gougelet, Bruno Passet, Camille Brochard, Delphine Le Corre, Caterina Luana Pitasi, Camille Joubel, Marine Sroussi, Claire Gallois, Julien Lavergne, Johan Castille, Marthe Vilotte, Nathalie Daniel-Carlier, Camilla Pilati, Aurélien de Reyniès, Fatima Djouadi, Sabine Colnot, Thierry André, Julien Taieb, Jean-Luc Vilotte, Béatrice Romagnolo & Pierre Laurent-Puig. (2024) Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer. Journal of Translational Medicine 22:1.
Crossref
Qixin Gan, Yue Li, Yuejun Li, Haifen Liu, Daochuan Chen, Lanxiang Liu & Churan Peng. (2024) Pathways and molecules for overcoming immunotolerance in metastatic gastrointestinal tumors. Frontiers in Immunology 15.
Crossref
Yiren Yang, Pengyu Liu, Mingyang Zhou, Linzhou Yin, Miao Wang, Ting Liu, Xiaowen Jiang & Huiyuan Gao. (2024) Small-molecule drugs of colorectal cancer: Current status and future directions. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1870:1, pages 166880.
Crossref
Jie Shao, Yi Zhang, Zhu Chang, Shiyao Du, Wei Li, Yushu Bai, Chunwen Lu & Tianming Xu. (2023) A novel ferroptosis-related microRNA signature with prognostic value in osteosarcoma. Acta Biochimica et Biophysica Sinica.
Crossref
Adriana Limone, Valentina Maggisano, Daniela Sarnataro & Stefania Bulotta. (2023) Emerging roles of the cellular prion protein (PrPC) and 37/67 kDa laminin receptor (RPSA) interaction in cancer biology. Cellular and Molecular Life Sciences 80:8.
Crossref
Jerson L. Silva, Debora Foguel, Vitor F. Ferreira, Tuane C. R. G. Vieira, Mayra A. Marques, Giulia D. S. Ferretti, Tiago F. Outeiro, Yraima Cordeiro & Guilherme A. P. de Oliveira. (2023) Targeting Biomolecular Condensation and Protein Aggregation against Cancer. Chemical Reviews 123:14, pages 9094-9138.
Crossref
Behnam Mohammadi, Feizhi Song, Andreu Matamoros-Angles, Mohsin Shafiq, Markus Damme, Berta Puig, Markus Glatzel & Hermann Clemens Altmeppen. (2022) Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein. Cell and Tissue Research 392:1, pages 215-234.
Crossref
Sophie Mouillet-Richard, Séverine Martin-Lannerée, Delphine Le Corre, Théo Z. Hirsch, Alexandre Ghazi, Marine Sroussi, Camilla Pilati, Aurélien de Reyniès, Fatima Djouadi, Nicolas Vodovar, Jean-Marie Launay & Pierre Laurent-Puig. (2022) A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer. Oncogene 41:38, pages 4397-4404.
Crossref
Paul C. McDonald & Shoukat Dedhar. (2022) New Perspectives on the Role of Integrin-Linked Kinase (ILK) Signaling in Cancer Metastasis. Cancers 14:13, pages 3209.
Crossref
Sophie Mouillet-Richard, Alexandre Ghazi & Pierre Laurent-Puig. (2021) The Cellular Prion Protein and the Hallmarks of Cancer. Cancers 13:19, pages 5032.
Crossref
Manqiu Ding, Yongqiang Chen, Yue Lang & Li Cui. (2021) The Role of Cellular Prion Protein in Cancer Biology: A Potential Therapeutic Target. Frontiers in Oncology 11.
Crossref